Guillain-Barré syndrome after the Zika epidemic in Colombia: A multicenter, matched case-control study.

Background: Zika produced the highest increase in the incidence of Guillain-Barré syndrome (GBS) in Latin America in the last decade. The Neuroinfections Emerging in the Americas Study (NEAS) was established in 2016 to investigate the association of emerging infectious disorders with GBS in Colombia. The present study assessed the role of preceding infections, including arboviruses and other pathogens, as risk factors for GBS.

Assessing plastic ingestion in the White stork (Ciconia ciconia) through regurgitated pellets.

Pollution is one of the main factors that threaten biodiversity nowadays. Plastic waste is a global problem which impacts not only on the marine environment but also on the terrestrial one. Great amounts of this kind of refuse are compiled in landfills, where lots of avian species feed.

Three new species of tiny tarantulas of the genus Thalerommata Ausserer, 1875 (Araneae, Theraphosidae) from northern Colombia.

Thalerommata Ausserer, 1875 is a theraphosid genus with very small species that resemble Trichopelma, although they lack the dot pattern on the abdomen. They are also distinguished from all other Theraphosidae by the presence of flattened, iridescent setae covering the abdomen, and sometimes, the legs too. Its current distribution includes the following countries: Argentina, Bahamas, Colombia, Cuba, Jamaica and Venezuela.

Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy.

Background And Purpose: Despite that incorporating antiangiogenic in combination with immune-checkpoint inhibitors as the standard first-line treatment for advanced clear cell renal cell cancer (ccRCC) yields promising outcomes, these regimens often lead to significant toxicity. However, a subgroup of patients has shown responsiveness to VEGFR tyrosine-kinase inhibitors (TKIs) in monotherapy, leading to the question of whether employing combination therapies can significantly enhance overall survival in all patients over monotherapy. Thus, we aim to identify gene expression signatures that can predict TKI response within subpopulations that might benefit from single-agent therapies, to minimize unnecessary exposure to combination therapies and their associated toxicities, as well as to discover new potential therapeutic targets to improve ccRCC treatment.